APA (7th ed.) Citation

Merli, M., Defrancesco, I., Visco, C., Besson, C., Di Rocco, A., Arcari, A., . . . Arcaini, L. (2020). Direct-acting antivirals in relapsed or refractory hepatitis C virus-associated diffuse large B-cell lymphoma. Leukemia & Lymphoma, 61(9), 2122. https://doi.org/10.1080/10428194.2020.1755859

Chicago Style (17th ed.) Citation

Merli, Michele, et al. "Direct-acting Antivirals in Relapsed or Refractory Hepatitis C Virus-associated Diffuse Large B-cell Lymphoma." Leukemia & Lymphoma 61, no. 9 (2020): 2122. https://doi.org/10.1080/10428194.2020.1755859.

MLA (9th ed.) Citation

Merli, Michele, et al. "Direct-acting Antivirals in Relapsed or Refractory Hepatitis C Virus-associated Diffuse Large B-cell Lymphoma." Leukemia & Lymphoma, vol. 61, no. 9, 2020, p. 2122, https://doi.org/10.1080/10428194.2020.1755859.